SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-430089
Filing Date
2013-11-06
Accepted
2013-11-06 16:12:14
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d597060d10q.htm 10-Q 388377
2 EX-10.1 d597060dex101.htm EX-10.1 11179
3 EX-31.1 d597060dex311.htm EX-31.1 6520
4 EX-31.2 d597060dex312.htm EX-31.2 6578
5 EX-32.1 d597060dex321.htm EX-32.1 4037
6 EX-32.2 d597060dex322.htm EX-32.2 4264
  Complete submission text file 0001193125-13-430089.txt   2352616

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acad-20130930.xml EX-101.INS 263758
8 XBRL TAXONOMY EXTENSION SCHEMA acad-20130930.xsd EX-101.SCH 25845
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20130930_cal.xml EX-101.CAL 43007
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20130930_def.xml EX-101.DEF 59514
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20130930_lab.xml EX-101.LAB 193163
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20130930_pre.xml EX-101.PRE 131605
Mailing Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 131196582
SIC: 2834 Pharmaceutical Preparations